Home » Search
Search Results
7,328 results for 'Search IBJ.com'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
Lilly diabetes drug matches competitors’ effectiveness
The Indianapolis drugmaker said dulaglutide performed as well as Victoza, a best-selling drug for Type 2 diabetics made by Denmark-based Novo Nordisk. Analysts think dulaglutide could reach annual sales of $1.5 billion.
Life sciences jobs pack 2-for-1 punch
While life sciences companies don’t rack up huge jobs numbers, their relatively high pay means that every job they create is worth two in the rest of the private sector.
Company news
Online physician visits could become far more common in Indiana this year under a bill pending in the General Assembly. House Bill 1258 would allow the large health insurer Anthem Blue Cross and Blue Shield to launch a pilot program using the Live Health Online technology it has developed with Massachusetts-based software firm American Well Corp. The technology—which allows doctors to make virtual house calls via a Skype-like video and chat portal—would expand access to health care by making physicians available at odd hours and to patients in far-flung areas. The pilot would be conducted by primary care physicians at Indianapolis-based American Health Network, a large primary care physician practice. The pilot could last as long as six months and would involve at least 200 online visits. After the pilot phase, the Medical Licensing Board of Indiana then would be able to decide whether to expand online visits statewide and under what restrictions, if any. Since 2003, the Medical Licensing Board has restricted those visits to patients and doctors who have had an in-person encounter. HB 1258 would remove that restriction, allowing doctor-patient consultations where no relationship existed.
Eli Lilly and Co. will acquire all assets of Germany-based Lohmann SE and its subsidiary, Lohmann Animal Health. The assets include vaccines and feed additives and manufacturing sites in Cuxhaven, Germany, and Winslow, Maine. No terms were released, but Indianapolis-based Lilly said Monday that its 2014 earnings forecast will be trimmed due to acquisition costs. Lohmann Animal Health had sales of $342 million in fiscal 2012. It has about 600 employees in more than 30 countries. In November, Reuters reported that Boehringer Ingelheim was considering an offer for Lohmann Animal Health estimated at $535 million. Lilly said the acquisition will significantly increase the ability of its Elanco Animal Health subsidiary to make vaccines. Competing in that market is a "cornerstone" of the subsidiary's long-term strategy, the company said. The deal is expected to close in the second quarter.
A panel of House lawmakers Feb. 20 approved a one-year ban on construction of nursing homes, according to the Associated Press. The measure passed the Ways and Means Committee 12-7. The Senate authors of the measure originally sought a five-year moratorium, but Ways and Means Chairman Tim Brown, R-Crawfordsville, suggested the length be trimmed to give lawmakers time to decide if a ban is needed. The ban is at the center of an ongoing debate between the state's existing nursing homes and developers leading a wave of construction across the state.
The University of Indianapolis plans to spend $50 million over five years on major construction projects. The bulk of the money will be spent on a 134,000-square-foot health sciences center, which will provide training space for UIndy’s nursing, physical therapy and other health care students, as well as for a community health care facility. Over the next two years, the UIndy will also renovate its Krannert Memorial Library, replace its Campus Apartments on Shelby Street with newer housing options and expand its science labs. UIndy also plans to hire additional faculty for key programs and launch men’s and women’s lacrosse teams.
Shares of Eli Lilly and Co. rose last week after the Indianapolis-based drugmaker revealed that an experimental drug boosted overall survival among lung cancer patients in a large Phase 3 trial. When ramucirumab was applied to non-small cell lung cancer, along with a traditional chemotherapy drug, it showed a statistically significant extension of the time of overall survival when compared with patients who only took the chemotherapy drug, Lilly said Feb. 19. The company plans to submit ramucirumab for market approval with the U.S. Food and Drug Administration later this year. The drug has already shown positive results as a treatment for gastric cancer, and Lilly is studying the drug as a liver cancer treatment as well. Wall Street analysts have modest expectations for ramucirumab. Bernstein Research analyst Tim Anderson expects sales next year of $167 million, ramping up to $669 million by 2020.
Lilly drug shows promise as lung cancer treatment
Shares of Eli Lilly and Co. rose as much as 3.8 percent Wednesday morning after the Indianapolis-based drugmaker revealed that an experimental drug boosted overall survival among lung cancer patients in a large trial.
Angie’s List earmarks $4M for lawsuit settlement
The Indy-based consumer reviews firm has set aside $4 million to settle a lawsuit alleging Angie’s List automatically renewed membership fees at a higher rate than members were led to believe.
Hoosier lawmakers attack Obamacare’s 30-hour rule
Lawmakers Young and Donnelly push restoration of 40-hour definition of full-time, but critics say their bills would gut Obamacare’s employer mandate and lead to a decline in employer insurance coverage.
Company news
Fritz French and Richard DiMarchi have raised $1.7 million from venture capitalists to launch Calibrium LLC, a biotech company that will develop diabetes drugs. French and DiMarchi were leaders of Marcadia Biotech Inc., which developed diabetes drugs based on DiMarchi's research as a chemistry professor at Indiana University. They sold the company for $287 million to Switzerland-based Roche in late 2010. In November, Calibrium struck a deal with Indiana University to fund 10 researchers in DiMarchi’s chemistry lab in Bloomington. Then in December, Calibrium secured convertible debt investments from two of the venture capital firms that backed Marcadia—San Francisco-based 5AM Ventures and Seattle-based Frazier Healthcare. Calibrium has hired Kristin Sherman as its chief financial officer; she held the same position at Marcadia. French said he expects more members of the Marcadia team to join Calibrium as its work advances.
Nearly two-thirds of the state’s nursing homes are now participating in partnerships with county-owned hospitals that effectively double their profit margins. The partnerships allow both hospitals and nursing homes to draw down extra federal money, which appears to give nursing homes at least 2 percent on top of their average profit margin of 2 percent. According to data from the Indiana State Department of Health, 329 nursing homes have sold their licenses to county-owned hospitals—63 percent of all nursing homes in the state and nearly 70 percent of those that offer beds to Medicaid patients. The partnerships with county-owned hospitals trigger larger payments from the federal agency that oversees the Medicare and Medicaid programs. Those payments average $71.54 per day for each Medicaid patient, according to analysis of Indiana data by the accounting firm Myers and Stauffer LC. It is unclear exactly how the hositals and nursing homes split that money, which totaled $313 million statewide last year. But Indiana Health Care Association officials said hospitals are paying nursing homes management fees that net out to about 2 percent of the nursing homes’ net patient revenue.
Hall Render Killian Heath & Lyman, the nation's largest health-care-focused law firm, ranked eighth on The Hill newspaper's 2013 top 10 list of Washington, D.C., lobbying firms based on the number of new client registrations. Last year, Indianapolis-based Hall Render registered 28 new clients. The firm created its federal legislative and regulatory advisory practice in 2012. The practice includes attorneys John Williams and John Render, as well as Andrew Coats, the son of Indiana Sen. Dan Coats.
BLOW: Conservatives losing on ‘pantywaist’ rhetoric
If one of the overt Democratic lines of attack against Republicans is that Republicans are conducting a war on women, one of the low-simmering, implicit lines of attack from Republicans is that Democrats are conducting a war on men, or at least traditional views of masculinity.
SHEPARD: Side with local government oversight when possible
Recent debates in the General Assembly about inspecting apartments for safety and sanitation purposes has highlighted the need for more energetic collaboration between state government and the people who lead cities and towns.
WAGNER: The long and winding road to recruit candidates
A few weeks ago, I received an email from a conservative special-interest group. It opened with four paragraphs about a Statehouse issue along with a list of House members the group wanted its supporters to call and email. But that’s not what caught my eye.
DANIELS: With jobs, it’s mobility, not just ‘equality,’ that matters
There is a lot of talk these days about income inequality—the growing gap between the incomes of the rich and poor. Arthur Brooks, president of the American Enterprise Institute, acknowledged in a recent speech to our Economic Club that the ”recovery” is working only for the rich: The poor are seeing no benefit from it, and income inequality is growing.
MARCUS: Rising prosperity still an elusive aspiration
Sometimes it seems our political leaders know only four-letter words like jobs. They often precede this with another four letter word: good.
ROGERS: Pence’s plan should be extended universally
I commend the governor for recognizing the state’s long overdue need to expand access to quality early-childhood education. In my years as a teacher, I found the difference between students arriving with a preschool education and those without to be profound.
STYRING: Stereotypes aside, business taxes really do matter
Gov. Mike Pence has proposed eliminating property taxes on business machinery and equipment. How exactly that is to be done, and over what time frame, he has left to the wisdom of the General Assembly.
HHGregg COO Throgmartin leaving company
Gregg W. Throgmartin is stepping down, a move that will leave the retailer without executive leadership from a member of its founding family for the first time since the first store opened in 1955.
Company news
Carmel-based Mainstreet Property Group will open 24 more health care facilities for Hoosier seniors during this year and the next two years. Those facilities, in total, would create 3,000 permanent jobs for Hoosiers–if they’re allowed to be built. The Indiana General Assembly is mulling a five-year moratorium on the construction of skilled nursing facilities, which if passed would prevent Mainstreet from building any new facilities not already begun by June 30. That legislation, known as Senate Bill 173, has passed the Indiana Senate and now awaits a hearing in the Indiana House. Zeke Turner, CEO of Mainstreet, said that if Indiana enacts a construction moratorium, Mainstreet will simply build more facilities in other states. The company has existing facilities in eight states and is working to expand in six more. Mainstreet alarmed older nursing home companies by developing 10 new facilities in the past five years—and breaking an unwritten rule of the industry by building in competitors’ back yards. That prompted the Indiana Health Care Association and other long-term-care groups to call for a ban on new construction.
Purdue Research Foundation and Bloomington-based medical-device maker Cook Medical have created a $12 million fund intended to help life-science businesses with connections to Purdue University. The Foundry Investment Fund will try to work with other investors to provide funding for companies that use Purdue-licensed technology or Purdue’s expertise in human and animal health and plant sciences. It typically would provide a match to outside investors’ funds. Outside investors could include venture capital firms, corporations, angel funding groups, or qualified individuals.
Indiana University Health announced a deal with UnitedHealthcare on Feb. 6, ending a contract dispute that had pushed IU Health doctors and hospitals out of the health insurance company’s discounted network Jan. 1. The two-year agreement gives UnitedHealthcare discounted rates retroactive to Jan. 1. Such discounts, which insurers negotiate with hospital systems, reduce prices 30 percent or more. The dispute between Indianapolis-based IU Health and Minnesota-based UnitedHealthcare dates to 2012, when the sides could not agree on a new long-term contract. They instead extended their previous agreement by one year, to Dec. 31, 2013, but then could not come to terms before the end of the year.
Testosterone-replacement rival of Lilly’s Axiron draws lawsuits
Abbott Laboratories and AbbVie Inc., the company it spun off last year, hid the dangers of using the testosterone replacement drug AndroGel, five men claim in lawsuits.
Lilly’s path to redemption: Turn new drugs into sales
This year will be ugly for Eli Lilly and Co., after the recent loss of two blockbusters, but it also gives Lilly an opportunity it hasn’t really had for nearly a decade: grow sales and profit by launching new drugs.